Virus News and Research

Latest Virus News and Research

Scientists explore antigenic imprinting in SARS-CoV-2

A recently published study compared monoclonal RBD antibody responses induced by SARS-CoV-2 Beta variant infections to antibodies induced by the ancestral virus in immunologically naive subjects.

12 Jul 2022

How may the genetic differences observed in the current monkeypox virus outbreak impact immune responses induced by VACV vaccines?

Researchers assessed the impact of the vaccinia virus vaccine on the immune response against the monkeypox virus.

12 Jul 2022

What is the long-term protection against COVID-19?

A new study describes the immunologic parameters associated with protection from COVID-19.

12 Jul 2022

Clinical presentation of monkeypox infection in two Israeli males

Researchers described the symptomatology and clinical manifestations of monkeypox infections among two Israeli patients.

12 Jul 2022

Researchers report a non-canonical RNA secondary structure present in monkeypox virus variants

Researchers described the evolutionary profile of the monkeypox virus.

12 Jul 2022

The impact of gene amplification in virus adaptation through intermediate hosts

Researchers assessed the impact of gene amplification on cross-species adaptation.

12 Jul 2022

Stinging nettle extract inhibits SARS-CoV-2 cell fusion

In a recent study posted to the bioRxiv* preprint server, researchers at Ghent University and KU Leuven, Belgium, demonstrated that Urtica dioica agglutinin (UDA), a monomeric lectin extracted from stinging nettle rhizomes, inhibited severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) cell to cell fusion.

12 Jul 2022

SARS-CoV-2 Omicron BA.5 tropism shifting back to ancestral strains

In a recent study posted to the medRxiv* pre-print server, researchers from Australia and Switzerland gathered data to help track and manage ongoing and future infection waves by new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant of concern (VOC) Omicron globally.

12 Jul 2022

Mild to moderate COVID causes inflammation of white matter in brain ten months later

In a recent work published in the medRxiv* preprint server, scientists in Germany performed neuropsychological evaluations and brain imaging of people who recovered from mild to moderate coronavirus disease 2019 (COVID-19).

12 Jul 2022

Persistence of SARS-CoV-2 in tissues leads to long COVID

PASC is likely the result of long-term persistence of SARS-CoV-2 in various tissues

11 Jul 2022

SARS-CoV-2 surrogates can survive on refrigerated or frozen meat products for up to 30 days, study finds

SARS-CoV-2 surrogates can survive on meat products in the refrigerator or the freezer, for up to 30 days. Those findings are published in Applied and Environmental Microbiology, a journal of the American Society for Microbiology.

11 Jul 2022

Scientists capture a clear picture of the nuclear pore complex using X-rays

Your body is made of close to 100 trillion cells that keep you healthy and alive. Each cell has billions of parts of its own, all of them working in tandem to keep life's processes moving.

11 Jul 2022

Researchers receive $3.25 million NIH grant to better understand the oral manifestations of HIV

Researchers at the Case Western Reserve University School of Dental Medicine will use a $3.25 million grant from the National Institutes of Health (NIH) to better understand how HIV impacts the human body, from mouth lesions to oral cancer.

11 Jul 2022

NIH launches clinical trial evaluating an experimental vaccine to prevent Nipah virus infection

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has launched an early-stage clinical trial evaluating an investigational vaccine to prevent infection with Nipah virus.

11 Jul 2022

SARS-CoV-2 spike protein downregulates ACE2 expression

In a new study, researchers observed the downregulation of ACE2 by SARS-CoV-2.

11 Jul 2022

Study assesses the potential of plant secondary metabolites as potential anti-COVID-19 agents

A new study has focused on identifying plant secondary metabolites (PSM) having a higher affinity for S-RBD of SARS-CoV-2.

11 Jul 2022

Experimental model reveals possible causes and treatments for long-COVID

In a recent study published in the journal Science Translational Medicine, researchers characterized long-term pulmonary consequences of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) mouse-adapted strain (MA10) infection in BALB/c laboratory mice.

11 Jul 2022

Universal influenza B vaccine confers robust and sustained cross-immune protection

A new universal flu vaccine protects against influenza B viruses, offering broad defense against different strains and improved immune protection, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.

8 Jul 2022

Scientists uncover how the innate immune system detects and fights HIV-1

Human immunodeficiency virus 1, more commonly known as HIV-1, is known for its uncanny ability to evade the immune system.

8 Jul 2022

Researchers analyze acute and post-acute COVID-19 presentations in athletes

Researchers at the University of São Paulo (USP) in Brazil analyzed data from 43 scientific articles describing the effects of COVID-19 on athletes and concluded that while the disease was asymptomatic or mild in the vast majority of cases (94%), about 8% of the subjects concerned had persistent symptoms affecting their performance and potentially preventing a return to training and competing.

8 Jul 2022

Virus News and Research

Latest Virus News and Research

Scientists explore antigenic imprinting in SARS-CoV-2

How may the genetic differences observed in the current monkeypox virus outbreak impact immune responses induced by VACV vaccines?

What is the long-term protection against COVID-19?

Clinical presentation of monkeypox infection in two Israeli males

Researchers report a non-canonical RNA secondary structure present in monkeypox virus variants

The impact of gene amplification in virus adaptation through intermediate hosts

Stinging nettle extract inhibits SARS-CoV-2 cell fusion

SARS-CoV-2 Omicron BA.5 tropism shifting back to ancestral strains

Mild to moderate COVID causes inflammation of white matter in brain ten months later

Persistence of SARS-CoV-2 in tissues leads to long COVID

SARS-CoV-2 surrogates can survive on refrigerated or frozen meat products for up to 30 days, study finds

Scientists capture a clear picture of the nuclear pore complex using X-rays

Researchers receive $3.25 million NIH grant to better understand the oral manifestations of HIV

NIH launches clinical trial evaluating an experimental vaccine to prevent Nipah virus infection

SARS-CoV-2 spike protein downregulates ACE2 expression

Study assesses the potential of plant secondary metabolites as potential anti-COVID-19 agents

Experimental model reveals possible causes and treatments for long-COVID

Universal influenza B vaccine confers robust and sustained cross-immune protection

Scientists uncover how the innate immune system detects and fights HIV-1

Researchers analyze acute and post-acute COVID-19 presentations in athletes

A new way of characterising biomolecules eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Newsletters you may be interested in